Aberrant expression of GM-CSF is associated with multiple neurological disorders such as Alzheimer’s disease (AD), vascular dementia, and multiple sclerosis [55, 56]. This evidence concerns the gene CSF2 and early-onset autosomal dominant Alzheimer disease.